ADD CONDITION

items per page

Gas Relief

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2021
Label revision date
September 29, 2025
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2021
Label revision date
September 29, 2025
Manufacturer
ARMY AND AIR FORCE EXCHANGE SERVICE
Registration number
M002
NDC root
55301-680

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

✓select™ is a chewable tablet that contains simethicone (a medication that helps relieve gas). It is designed to provide relief from the discomfort associated with pressure, bloating, and fullness caused by gas. With a pleasant cherry flavor, these tablets can help you feel more comfortable by alleviating the symptoms of gas quickly and effectively.

Uses

If you're experiencing discomfort from gas, this medication can help relieve the pressure, bloating, and fullness that often accompany it. Many people find that it effectively eases these uncomfortable sensations, allowing for a more pleasant experience after meals or during times of digestive distress.

You can trust that this medication is designed specifically for these issues, providing relief from bloating, pressure, and overall discomfort related to gas.

Dosage and Administration

When using this medication, it's important to follow the instructions carefully to ensure your safety and effectiveness. You should not take more than the recommended amount. If you're an adult or a child aged 12 years and older, you can take 1 or 2 chewable tablets after meals and at bedtime as needed. Make sure to chew or crush the tablets completely before swallowing them; do not swallow them whole.

It's crucial to keep track of how many tablets you take. You should not exceed 4 chewable tablets in a 24-hour period unless your doctor has specifically directed you to do so. If you are considering giving this medication to a child under 12 years old, please consult a doctor first for guidance.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

It's important to keep this medication out of reach of children to prevent accidental ingestion. Always ensure that it is stored safely and securely. If you have any concerns about side effects or how to use this medication, please consult your healthcare provider for guidance.

Warnings and Precautions

It’s important to keep this medication out of reach of children to ensure their safety. While there are no specific general precautions or laboratory tests mentioned, always be mindful of how you store and handle medications.

If you have any concerns or experience unusual symptoms while using this medication, it’s best to consult your doctor for guidance. Your health and safety are paramount, so don’t hesitate to seek professional advice if needed.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it’s crucial to seek immediate medical help.

In case of an emergency, you should call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no specific information available about the use of simethicone during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions related to its use in pregnant individuals have not been clearly established.

Before taking simethicone or any medication while pregnant, it’s best to consult with your healthcare provider to discuss potential risks and benefits tailored to your situation. Your health and the health of your baby are the top priority, so always seek professional advice when considering any treatment during pregnancy.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children. For adults and children aged 12 years and older, the recommended dosage is 1 or 2 chewable tablets taken as needed after meals and at bedtime. However, you should not exceed 4 chewable tablets in a 24-hour period unless directed by a doctor.

If your child is under 12 years old, it's essential to consult a doctor before giving them this medication. Always prioritize safety and follow the guidance of a healthcare professional when it comes to treating children.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and may be taking multiple medications, it’s always a good idea to consult with a healthcare provider before starting any new medication. They can help ensure that the treatment is safe and appropriate for your individual health situation.

If you or a loved one is an older adult, be sure to discuss any concerns about potential side effects or interactions with other medications you may be taking. Your healthcare provider can provide guidance tailored to your specific needs.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally around 25ºC (77ºF). It’s acceptable for the temperature to vary between 15ºC and 30ºC (59ºF to 86ºF), but try to keep it within this range. Make sure to protect the product from moisture, as this can affect its quality.

When handling the product, check the packaging carefully. If the outer package is opened or if the blister (the sealed compartment that holds the product) is torn or broken, do not use it. This tamper-evident feature is important for your safety, ensuring that the product is intact and uncontaminated.

Additional Information

You should take this medication orally. It's important to chew or crush the tablets completely before swallowing them; do not swallow the tablets whole. This ensures that the medication is properly absorbed and works effectively.

FAQ

What is ✓select™ used for?

✓select™ is used for the relief of pressure, bloating, and fullness commonly referred to as gas.

How should I take ✓select™?

You should chew or crush the tablets completely before swallowing; do not swallow them whole. Adults and children 12 years and over can take 1 or 2 chewable tablets as needed after meals and at bedtime.

What is the maximum dosage for ✓select™?

Do not exceed 4 chewable tablets in 24 hours unless directed by a doctor.

Are there any contraindications for ✓select™?

No contraindications are listed for ✓select™.

Is ✓select™ safe to use during pregnancy?

The insert does not provide specific information regarding the use of simethicone during pregnancy.

Can nursing mothers use ✓select™?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

What should I do if the package is tampered with?

Do not use ✓select™ if the package is opened or if the blister unit is torn, broken, or shows any signs of tampering.

How should I store ✓select™?

Store ✓select™ at 25ºC (77ºF), with excursions permitted between 15º-30ºC (59º-86ºF), and protect it from moisture.

What flavor does ✓select™ come in?

✓select™ comes in a cherry flavor.

What should I do if I have questions about using ✓select™?

If you have questions, you can contact LNK International, Inc. at 1-800-426-9391.

Packaging Info

Below are the non-prescription pack sizes of Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gas Relief.
Details

Drug Information (PDF)

This file contains official product information for Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and fullness commonly referred to as gas. It effectively alleviates symptoms of bloating, pressure, and discomfort associated with gastrointestinal gas.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and not exceed the directed amount. For adults and children aged 12 years and older, the recommended dosage is 1 to 2 chewable tablets taken as needed after meals and at bedtime. It is imperative that the tablets are chewed or crushed completely before swallowing; they should not be swallowed whole.

The maximum allowable dosage for this population is 4 chewable tablets within a 24-hour period, unless otherwise directed by a healthcare professional. For children under the age of 12, it is advised to consult a doctor for appropriate dosing recommendations.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

It is imperative to keep this medication out of reach of children to prevent accidental ingestion or misuse. Healthcare professionals should ensure that patients and caregivers are aware of this critical safety measure to mitigate the risk of pediatric exposure.

Currently, there are no specific general precautions or laboratory tests associated with the use of this medication. Healthcare providers should remain vigilant and monitor for any emerging safety information or guidelines that may be issued in the future.

Side Effects

Patients should be advised to keep this medication out of reach of children. This warning is critical to prevent accidental ingestion or exposure, which could lead to serious adverse reactions.

No additional adverse reactions, including serious or common events, have been specified in the provided data. It is essential for healthcare providers to monitor patients for any unexpected effects and to report such occurrences as part of ongoing safety evaluations.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gas Relief.
Details

Pediatric Use

Pediatric patients should be kept out of reach of children. For adults and children aged 12 years and older, the recommended dosage is 1 or 2 chewable tablets as needed after meals and at bedtime, with a maximum of 4 chewable tablets in a 24-hour period unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of simethicone during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. There are no known safety concerns, dosage modifications, or special precautions outlined for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of simethicone in women who are pregnant or planning to become pregnant, and weigh the potential benefits against any unknown risks. Further studies may be necessary to fully understand the implications of simethicone use during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as per local guidelines.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

The product is supplied in a tamper-evident package. It is essential to refrain from using the product if the outer package is opened or if the blister is torn or broken.

Storage conditions require the product to be maintained at a temperature of 25ºC (77ºF), with permissible excursions between 15ºC and 30ºC (59ºF to 86ºF). Additionally, the product must be protected from moisture to ensure its integrity and efficacy.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients to chew or crush the tablets completely before swallowing, as the tablets should not be swallowed whole.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Gas Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.